Assessing Patient Readiness for an Electronic Patient-Reported Outcome-Based Symptom Management Intervention in a Multisite Study.

Autor:	Paudel R; Dana-Farber Cancer Institute, Boston, MA., Tramontano AC; Dana-Farber Cancer Institute, Boston, MA., Cronin C; Dana-Farber Cancer Institute, Boston, MA., Wong SL; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Dizon DS; Lifespan Cancer Institute and Brown University, Providence, RI., Jenkins HH; West Virginia University Cancer Center, Morgantown, WV., Bian J; Maine Medical Center, Portland, ME., Osarogiagbon RU; Baptist Memorial Healthcare Corporation, Memphis, TN., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA.
Jazyk:	angličtina
Zdroj:	JCO oncology practice [JCO Oncol Pract] 2024 Jan; Vol. 20 (1), pp. 77-84. Date of Electronic Publication: 2023 Nov 27.
DOI:	10.1200/OP.23.00339
Abstrakt:	Purpose: While the use of electronic patient-reported outcomes (ePROs) in routine clinical practice is increasing, barriers to patient engagement limit adoption. Studies have focused on technology access as a key barrier, yet other characteristics may also confound readiness to use ePROs including patients' confidence in using technology and confidence in asking clinicians questions. Methods: To assess readiness to use ePROs, adult patients from six US-based health systems who started a new oncology treatment or underwent a cancer-directed surgery were invited to complete a survey that assessed access to and confidence in the use of technology, ease of asking clinicians questions about health, and symptom management self-efficacy. Multivariable ordinal logistic regression models were fit to assess the association between technology confidence, ease of asking questions, and symptom management self-efficacy. Results: We contacted 3,212 individuals, and 1,043 (33%) responded. The median age was 63 years, 68% were female, and 75% reported having access to patient portals. Over 80% had two or more electronic devices. Most patients reported high technology confidence, higher ease of asking clinicians questions, and high symptom management self-efficacy (n = 692; 66%). Patients with high technology confidence also reported higher ease of asking nurses about their health (adjusted odds ratio [AOR], 4.58 [95% CI, 2.36 to 8.87]; P ≤ .001). Those who reported higher ease of asking nurses questions were more likely to report higher confidence in managing symptoms (AOR, 30.54 [95% CI, 12.91 to 72.30]; P ≤ .001). Conclusion: Patient readiness to use ePROs likely depends on multiple factors, including technology and communication confidence, and symptom management self-efficacy. Future studies should assess interventions to address these factors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu